vs

Side-by-side financial comparison of Cellectis S.A. (CLLS) and Direct Digital Holdings, Inc. (DRCT). Click either name above to swap in a different company.

Cellectis S.A. is the larger business by last-quarter revenue ($9.5M vs $8.4M, roughly 1.1× Direct Digital Holdings, Inc.). Direct Digital Holdings, Inc. runs the higher net margin — -138.7% vs -265.9%, a 127.2% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs -7.4%).

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Devolver Digital, Inc. is an American video game publisher based in Austin, Texas, specializing in the publishing of indie games. The company was founded in June 2009 by Nigel Lowrie, Harry Miller, Graeme Struthers, Rick Stults, and Mike Wilson, five executives who had been involved with Gathering of Developers and Gamecock Media Group, which published games on developer-friendly terms, but due to the high cost associated with releasing retail games saw themselves acquired and dissolved by la...

CLLS vs DRCT — Head-to-Head

Bigger by revenue
CLLS
CLLS
1.1× larger
CLLS
$9.5M
$8.4M
DRCT
Growing faster (revenue YoY)
CLLS
CLLS
+382.4% gap
CLLS
375.0%
-7.4%
DRCT
Higher net margin
DRCT
DRCT
127.2% more per $
DRCT
-138.7%
-265.9%
CLLS

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CLLS
CLLS
DRCT
DRCT
Revenue
$9.5M
$8.4M
Net Profit
$-25.3M
$-11.7M
Gross Margin
26.8%
Operating Margin
-181.1%
-53.4%
Net Margin
-265.9%
-138.7%
Revenue YoY
375.0%
-7.4%
Net Profit YoY
-51.9%
-434.7%
EPS (diluted)
$-0.28
$-74.97

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLLS
CLLS
DRCT
DRCT
Q4 25
$8.4M
Q3 25
$8.0M
Q2 25
$10.1M
Q1 25
$8.2M
Q4 24
$9.1M
Q3 24
$9.1M
Q2 24
$9.5M
$21.9M
Q1 24
$22.3M
Net Profit
CLLS
CLLS
DRCT
DRCT
Q4 25
$-11.7M
Q3 25
$-2.7M
Q2 25
$-2.2M
Q1 25
$-2.4M
Q4 24
$-2.2M
Q3 24
$-2.7M
Q2 24
$-25.3M
$-590.0K
Q1 24
$-775.0K
Gross Margin
CLLS
CLLS
DRCT
DRCT
Q4 25
26.8%
Q3 25
27.7%
Q2 25
35.1%
Q1 25
29.3%
Q4 24
32.5%
Q3 24
38.7%
Q2 24
27.1%
Q1 24
22.4%
Operating Margin
CLLS
CLLS
DRCT
DRCT
Q4 25
-53.4%
Q3 25
-49.0%
Q2 25
-23.9%
Q1 25
-48.1%
Q4 24
-51.8%
Q3 24
-40.3%
Q2 24
-181.1%
-9.4%
Q1 24
-12.6%
Net Margin
CLLS
CLLS
DRCT
DRCT
Q4 25
-138.7%
Q3 25
-33.6%
Q2 25
-22.2%
Q1 25
-28.9%
Q4 24
-24.0%
Q3 24
-29.6%
Q2 24
-265.9%
-2.7%
Q1 24
-3.5%
EPS (diluted)
CLLS
CLLS
DRCT
DRCT
Q4 25
$-74.97
Q3 25
$-0.24
Q2 25
$-0.23
Q1 25
$-0.35
Q4 24
$-90.17
Q3 24
$-0.71
Q2 24
$-0.28
$-0.16
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLLS
CLLS
DRCT
DRCT
Cash + ST InvestmentsLiquidity on hand
$149.0M
$728.0K
Total DebtLower is stronger
Stockholders' EquityBook value
$148.6M
$-7.0M
Total Assets
$407.1M
$20.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLLS
CLLS
DRCT
DRCT
Q4 25
$728.0K
Q3 25
$871.0K
Q2 25
$1.6M
Q1 25
$1.8M
Q4 24
$1.4M
Q3 24
$4.1M
Q2 24
$149.0M
$1.1M
Q1 24
$3.3M
Total Debt
CLLS
CLLS
DRCT
DRCT
Q4 25
Q3 25
$10.8M
Q2 25
$33.5M
Q1 25
$32.9M
Q4 24
Q3 24
$150.0K
Q2 24
$34.8M
Q1 24
$32.4M
Stockholders' Equity
CLLS
CLLS
DRCT
DRCT
Q4 25
$-7.0M
Q3 25
$-6.7M
Q2 25
$-24.6M
Q1 25
$-23.3M
Q4 24
$-19.7M
Q3 24
$-16.7M
Q2 24
$148.6M
$-10.5M
Q1 24
$-7.5M
Total Assets
CLLS
CLLS
DRCT
DRCT
Q4 25
$20.2M
Q3 25
$22.5M
Q2 25
$23.3M
Q1 25
$23.8M
Q4 24
$26.0M
Q3 24
$31.3M
Q2 24
$407.1M
$48.5M
Q1 24
$52.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLLS
CLLS
DRCT
DRCT
Operating Cash FlowLast quarter
$28.9M
$-1.9M
Free Cash FlowOCF − Capex
$27.6M
FCF MarginFCF / Revenue
290.5%
Capex IntensityCapex / Revenue
13.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLLS
CLLS
DRCT
DRCT
Q4 25
$-1.9M
Q3 25
$-1.6M
Q2 25
$-2.7M
Q1 25
$-2.7M
Q4 24
$-1.6M
Q3 24
$3.0M
Q2 24
$28.9M
$-4.4M
Q1 24
$-5.7M
Free Cash Flow
CLLS
CLLS
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$27.6M
Q1 24
FCF Margin
CLLS
CLLS
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
290.5%
Q1 24
Capex Intensity
CLLS
CLLS
DRCT
DRCT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
13.2%
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLLS
CLLS

Segment breakdown not available.

DRCT
DRCT

Buy Side Advertising$8.2M98%
Other$183.0K2%

Related Comparisons